dc.contributor.author | Shoib, S. | |
dc.contributor.author | Bharati-Sinha, V. | |
dc.contributor.author | Javed, S. | |
dc.contributor.author | Gürcan, A. | |
dc.contributor.author | Gürcan, G. | |
dc.contributor.author | Das, S. | |
dc.contributor.author | Chandradasa, M. | |
dc.contributor.author | Saeed, F. | |
dc.date.accessioned | 2022-02-25T02:49:07Z | |
dc.date.available | 2022-02-25T02:49:07Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Health Science Reports.2022;5(2):e506. | en_US |
dc.identifier.issn | 2398-8835 | |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/24484 | |
dc.description | Indexed in MEDLINE. | en_US |
dc.description.abstract | No abstract available | en_US |
dc.language.iso | en | en_US |
dc.publisher | John Wiley and Sons | en_US |
dc.subject | COVID-19 | en_US |
dc.title | The disquietude of clozapine continuation during the COVID-19 pandemic. | en_US |
dc.type | Article | en_US |